Filmed on location in New York during the Great Debates & Updates in Hematologic Malignancies 2015, this webcast is part of a series that focuses on controversial areas in the management of hematologic malignancies as nationally-recognized thought leaders take opposing sides on topics of clinical interest.
In this presentation, Dr. Amy E. DeZern discusses the management of cases of lower-risk MDS lacking del5q and refractory to ESAs.
© 2015 Imedex, LLC.
